Preclinical Results For Pluristem Therapeutics’s PLX-PAD Cells In Tendon Injury Presented At American Academy of Orthopaedic Surgeons’ Annual Meeting

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HAIFA, Israel, March 12, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, today announced that Dr. Scott Rodeo of New York’s Hospital for Special Surgery (HSS) presented his research findings in a scientific poster titled, “Use of Human Placental-Derived Adherent Stromal Cells Improves Tendon Healing in a Preclinical Model of Tendon Injury,” at the American Academy of Orthopedic Surgeons’ (AAOS) Annual Meeting, on March 11-15 in New Orleans. - See more at: http://www.globenewswire.com/news-release/2014/03/12/617606/10072308/en/Preclinical-Results-for-Pluristem-s-PLX-PAD-Cells-in-Tendon-Injury-Presented-at-American-Academy-of-Orthopedic-Surgeons-Annual-Meeting.html#sthash.AJgzyRLk.dpuf

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC